Technology

iDEL Therapeutics Launches with €9 Million Seed Financing Led by BiomedVC to Advance Oncology Pipeline Based on Direct Cytosolic Transfer Technology

Newly launched biotech company iDEL Therapeutics is pioneering a pipeline of cancer drugs that are delivered directly into the cytosol of tumor cells

Read Full Article

This article was originally published on globenewswire_fr. Click the button above to read the complete article.